Clinical Trial Update: A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer [Phase 1]

View source ↗

Summary

This is a Phase I prevention trial evaluating atorvastatin in women at increased risk for breast cancer. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Ductal Hyperplasia
• Breast Cancer
• Ductal Carcinoma in Situ
• Lobular Carcinoma in Situ

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Atypical Ductal Breast Hyperplasia, Breast Cancer | Phase 1 | Status: COMPLETED